-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Reiterates Neutral on Fulgent Genetics, Lowers Price Target to $15

Benzinga·05/05/2026 18:11:44
Listen to the news
Piper Sandler analyst David Westenberg reiterates Fulgent Genetics (NASDAQ:FLGT) with a Neutral and lowers the price target from $30 to $15.